Previous 10 | Next 10 |
RANCHO CORDOVA, Calif. , June 18, 2019 /PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing, today announced that it has received Health Canada approval of its nex...
RANCHO CORDOVA, Calif. , June 5, 2019 /PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing, today announced that it will participate in and exhibit its novel PXP® System, for point-of...
RANCHO CORDOVA, Calif. , June 4, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced that it has amended its Sixth Amended and Restated Certificate of Incorp...
Cesca Therapeutics Inc. (NASDAQ:KOOL) Q1 2019 Earnings Conference Call May 14, 2019 4:30 PM ET Company Participants Paula Schwartz - Managing Director, Rx Communications Chris Xu - Chairman and Chief Executive Officer Jeff Cauble - Principal Accounting Officer Conference Cal...
Cesca Therapeutics (NASDAQ: KOOL ): Q1 GAAP EPS of -$0.08 in-line. More news on: Cesca Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
RANCHO CORDOVA, Calif. , May 14, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced financial and operating results for the first quarter ended March 31, 2...
RANCHO CORDOVA, Calif. , May 7, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that the Company will release its financial results fo...
RANCHO CORDOVA, Calif. , April 17, 2019 /PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing, today announced the release of the enhanced X-MINI ® CD3 Selection Kit for the re...
RANCHO CORDOVA, Calif. , April 10, 2019 /PRNewswire/ -- ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that its AXP®...
Cesca Therapeutics Inc. (KOOL) Q4 2018 Earnings Conference Call March 25, 2019 4:30 PM ET Company Participants Paula Schwartz - Managing Director, Rx Communications Chris Xu - Chairman and Chief Executive Officer Jeff Cauble - Principal Accounting Officer Conference Call Parti...
News, Short Squeeze, Breakout and More Instantly...
Cesca Therapeutics Inc. Company Name:
KOOL Stock Symbol:
NASDAQ Market:
Cesca Therapeutics Inc. Website:
RANCHO CORDOVA, Calif. , Oct. 31, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing for regenerative medicine, today announced that the company will change its name to ThermoGenesis Holdings, Inc. ("ThermoGenesis") in order...
RANCHO CORDOVA, Calif. , Oct. 24, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Chris Xu , Ph.D., Chairman and Chief Executive Officer, will present a...
RANCHO CORDOVA, Calif. , Oct. 22, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary, today announced that the company...